Kaplan–Meier survival analysis confirmed a negative correlation between high SPT6 expression (SPT6high) and glioma (WHO grade II–IV) patient survival (Supplementary Fig. 7e). The gene discussed is SUPT6H; the disease is central nervous system cancer.